| Primary |
| Product Used For Unknown Indication |
50.8% |
| Blood Testosterone Decreased |
26.5% |
| Hormone Replacement Therapy |
5.1% |
| Hypogonadism |
4.2% |
| Diabetes Mellitus |
2.9% |
| Anxiety |
1.3% |
| Fatigue |
1.3% |
| Blood Cholesterol Increased |
1.0% |
| Erectile Dysfunction |
1.0% |
| Gastrooesophageal Reflux Disease |
1.0% |
| Hypertension |
1.0% |
| Insomnia |
1.0% |
| Androgen Deficiency |
0.6% |
| Cardiovascular Event Prophylaxis |
0.6% |
| Accidental Exposure To Product |
0.3% |
| Anticoagulant Therapy |
0.3% |
| Antiviral Prophylaxis |
0.3% |
| Asthenia |
0.3% |
| Blood Iron Decreased |
0.3% |
| Bone Density Decreased |
0.3% |
|
| Drug Ineffective |
12.6% |
| Skin Exfoliation |
8.4% |
| Application Site Exfoliation |
7.4% |
| Wrong Technique In Drug Usage Process |
7.4% |
| Application Site Rash |
6.3% |
| Application Site Pain |
5.3% |
| Incorrect Dose Administered |
5.3% |
| Oedema Peripheral |
5.3% |
| Weight Increased |
5.3% |
| Skin Burning Sensation |
4.2% |
| Urticaria |
4.2% |
| Application Site Pruritus |
3.2% |
| Application Site Urticaria |
3.2% |
| Arthritis |
3.2% |
| Blood Glucose Increased |
3.2% |
| Blood Testosterone Decreased |
3.2% |
| Drug Administered At Inappropriate Site |
3.2% |
| Hypersensitivity |
3.2% |
| Local Swelling |
3.2% |
| Nightmare |
3.2% |
|
| Secondary |
| Product Used For Unknown Indication |
35.6% |
| Blood Testosterone Decreased |
27.4% |
| Hormone Replacement Therapy |
12.3% |
| Hypogonadism |
5.5% |
| Anticoagulant Therapy |
1.4% |
| Antiviral Prophylaxis |
1.4% |
| Asthenia |
1.4% |
| Diabetes Mellitus |
1.4% |
| Erectile Dysfunction |
1.4% |
| Essential Hypertension |
1.4% |
| Fatigue |
1.4% |
| Hypercholesterolaemia |
1.4% |
| Hyperglycaemia |
1.4% |
| Hypertension |
1.4% |
| Hyperuricaemia |
1.4% |
| Muscle Building Therapy |
1.4% |
| Prophylaxis |
1.4% |
| Weight Loss Diet |
1.4% |
|
| Drug Ineffective |
10.8% |
| Application Site Rash |
8.1% |
| Arthritis |
8.1% |
| Tremor |
8.1% |
| Anaphylactic Shock |
5.4% |
| Application Site Irritation |
5.4% |
| Application Site Pain |
5.4% |
| Fatigue |
5.4% |
| Inappropriate Schedule Of Drug Administration |
5.4% |
| Skin Exfoliation |
5.4% |
| Testicular Pain |
5.4% |
| Underdose |
5.4% |
| Breast Pain |
2.7% |
| Constipation |
2.7% |
| Dry Eye |
2.7% |
| Erythema Multiforme |
2.7% |
| Lethargy |
2.7% |
| Mood Altered |
2.7% |
| Prescribed Overdose |
2.7% |
| Rash |
2.7% |
|
| Concomitant |
| Product Used For Unknown Indication |
23.2% |
| Diabetes Mellitus |
12.5% |
| Blood Testosterone Decreased |
10.7% |
| Blood Pressure |
7.1% |
| Prostatic Disorder |
7.1% |
| Type 2 Diabetes Mellitus |
7.1% |
| Blood Cholesterol |
3.6% |
| Drug Dependence |
3.6% |
| Hypertension |
3.6% |
| Neuropathy Peripheral |
3.6% |
| Atrial Fibrillation |
1.8% |
| Bladder Disorder |
1.8% |
| Blood Cholesterol Increased |
1.8% |
| Blood Pressure Abnormal |
1.8% |
| Blood Testosterone |
1.8% |
| Blood Testosterone Abnormal |
1.8% |
| Dependence |
1.8% |
| Depression |
1.8% |
| Ear Disorder |
1.8% |
| Enzyme Supplementation |
1.8% |
|
| Weight Decreased |
18.2% |
| Alanine Aminotransferase Increased |
9.1% |
| Blood Glucose Increased |
9.1% |
| Haemoptysis |
9.1% |
| Impaired Healing |
9.1% |
| Prostatic Specific Antigen Increased |
9.1% |
| Psoriatic Arthropathy |
9.1% |
| Vitamin D Decreased |
9.1% |
| Weight Increased |
9.1% |
| Wrong Technique In Drug Usage Process |
9.1% |
|
